Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review

Mikael L Soucisse1,2, Joshua Lansom1, Mohammad S Alshahrani1,3

  • 1Department of Surgery, University of New South Wales, St George Hospital, Sydney, Australia.

ANZ Journal of Surgery
|August 8, 2020
PubMed

Insights

Mucinous appendiceal neoplasms (MANs) are rare tumors causing pseudomyxoma peritonei. This review clarifies their histology and management, aiming to optimize treatment for better patient outcomes.

Area of Science:

  • Gastroenterology and Surgical Oncology

Background:

  • Mucinous appendiceal neoplasms (MANs) are rare tumors, often presenting insidiously and leading to pseudomyxoma peritonei.
  • MANs exhibit a wide spectrum of presentations, stages, and cytologic features, necessitating tailored surgical approaches from appendicectomy to cytoreduction with hyperthermic intraperitoneal chemotherapy.

Purpose of the Study:

  • To review the most recent histological classifications of MANs.
  • To clarify optimal management strategies for MANs based on clinical presentation and histological subtypes.

Main Methods:

  • Literature review focusing on recent advancements in MANs classification and treatment guidelines.
  • Analysis of histopathological findings and their correlation with clinical management.

Main Results:

  • Histopathological classification of MANs is complex and subject to ongoing debate due to terminology inconsistencies.
  • Despite challenges in classification, curative treatment is achievable for most patients, with the primary goal being to minimize operative morbidity while maintaining oncologic control.

Conclusions:

  • Standardizing histopathological terminology is crucial for consistent diagnosis and treatment planning of MANs.
  • A clear understanding of MANs histology and recent classifications is essential for clinicians to provide optimal, individualized patient management.